Corvus Pharmaceuticals CRVS Change in Other Current Assets
Change in Other Current Assets at other companies
Other financials
Where this comes from
Reported directly by Corvus Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherCurrentAssets.
The official record: Corvus Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Corvus Pharmaceuticals's change in other current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Corvus Pharmaceuticals's change in other current assets?
- Corvus Pharmaceuticals (CRVS) reported change in other current assets of $865K in Q1 2026.
- How has Corvus Pharmaceuticals's change in other current assets changed year-over-year?
- Corvus Pharmaceuticals's change in other current assets increased by 28933.3% year-over-year, from -$3K to $865K.
- What is the long-term trend for Corvus Pharmaceuticals's change in other current assets?
- Over 2 years (2022 to 2025), Corvus Pharmaceuticals's change in other current assets has grown at a 44.4% compound annual growth rate (CAGR), from -$107K to $223K.
- What does change in other current assets mean?
- Change in miscellaneous current assets not classified in specific working capital categories.